Related Experiment Video
Updated: Aug 26, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Use of covered stents to treat complex cerebrovascular diseases: Expert consensus
Yueqi Zhu1, Huaqiao Tan2, Zhongxue Wu3
1Department of Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
Insights
Covered stents offer a new endovascular approach for complex cerebrovascular diseases (CCVDs), enabling arterial wall reconstruction. This expert consensus provides guidance for standardizing their clinical application.
Area of Science:
- Endovascular neurosurgery
- Cerebrovascular disease treatment
- Medical device innovation
Background:
- Complex cerebrovascular diseases (CCVDs) present significant treatment challenges.
- Existing endovascular therapies like embolization and flow diverters have limitations.
- Covered stents represent a novel approach focusing on arterial wall reconstruction.
Purpose of the Study:
- To establish an expert consensus on the use of covered stents for CCVDs.
- To summarize current outcomes and propose clinical application standards.
- To guide individualized intraluminal reconstruction treatment strategies.
Main Methods:
- Development of an expert consensus by leading neurointervention specialists in China.
- Review and synthesis of clinical results from covered stent application in CCVDs.
- Formulation of standardized recommendations for clinical practice.
Main Results:
- Covered stents have demonstrated positive outcomes in treating thousands of CCVD patients.
- This technique allows for intraluminal reconstruction, addressing arterial wall defects.
- The consensus provides a framework for the standardized application of covered stents.
Conclusions:
- Covered stent insertion is an effective endovascular treatment for CCVDs.
- Standardization is crucial for optimizing the clinical application of this technique.
- This consensus aims to enhance patient care through individualized treatment approaches.
Abstract:
The treatment of complex cerebrovascular diseases (CCVDs) at the skull base, such as complex intracranial aneurysms, carotid-cavernous sinus fistulas, and intracranial artery traumatic injuries, is a difficult clinical problem despite advances in endovascular and surgical therapies. Covered stents or stent graft insertion is a new concept for endovascular treatment that focuses on arterial wall defect reconstruction, differing from endovascular lesion embolization or flow diverter therapies. In recent years, covered stents specifically designed for cerebrovascular treatment have been applied in the clinical setting, allowing thousands of patients with CCVDs to undergo intraluminal reconstruction treatment and achieving positive results, even in the era of flow diverters. Since there is no unified reference standard for the application of covered stents for treating CCVDs, it is necessary to further standardize and guide the clinical application of this technique. Thus, we organized authoritative experts in the field of neurointervention in China to write an expert consensus, which aims to summarize the results of covered stent insertion in the treatment of CCVDs and propose suitable standards for its application in the clinical setting. Based on the contents of this consensus, clinicians can use individualized intraluminal reconstruction treatment techniques for patients with CCVDs.
More Related Videos
14:58Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Mitral Stenosis III: Medical Management
Atherosclerosis III: Management
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...